Roux-en-Y surgery can reverse insulin treatment in T2DM

Roux-en-Y surgery can reverse insulin treatment in T2DM

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study published online Jan. 8 in Diabetes Care.

Ali Ardestani, M.D., from Brigham and Women's Hospital in Boston, and colleagues examined changes in after bariatric surgery in a cohort of 5,225 patients with I-T2D. RYGB was compared with laparoscopic adjustable gastric banding (LAGB). To control for differences in patterns between the two types of , the authors conducted a case-matched analysis.

The researchers found that 62 percent of I-T2D patients who underwent RYGB were off insulin at 12 months, compared with 34 percent of those who underwent LAGB (P < 0.001). RYGB strongly predicted insulin cessation at one and 12 months postoperatively. The proportion of insulin cessation was significantly higher in the RYGB group than the LAGB group at three months in the case-matched analysis (P = 0.03), and at all time points after RYGB, the diabetes remission rate was higher. RYGB predicted insulin therapy cessation early after surgery, in a weight-independent manner, while insulin cessation after LAGB was associated with weight loss.

"These findings support RYGB as the procedure of choice for reversing I-T2D," the authors write.


Explore further

Two JAMA Surgery studies examine bariatric surgery for type 2 diabetes treatment

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Copyright © 2015 HealthDay. All rights reserved.

Citation: Roux-en-Y surgery can reverse insulin treatment in T2DM (2015, January 21) retrieved 24 August 2019 from https://medicalxpress.com/news/2015-01-roux-en-y-surgery-reverse-insulin-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more